THÔNG TIN TÀI LIỆU
Innovation in the pharmaceutical industry: New estimates of R&D costs J Health Econ 2016;47:20–33 276 Abrams J, Conley B, Mooney M, et al National Cancer Institute's precision medicine initiatives for the new national clinical trials network Am Soc Clin Oncol Educ Book 2014;71–76 277 Johnson JA Ethnic differences in cardiovascular drug response: Potential contribution of pharmacogenetics Circulation 2008;118:1383– 1393 278 Taylor MR, Sun AY, Davis G, et al Race, common genetic variation, and therapeutic response disparities in heart failure JACC Heart Fail 2014;2:561–572 279 Azzimato V, Genneback N, Tabish AM, Buyandelger B, Knoll R Desmin, desminopathy and the complexity of genetics J Mol Cell Cardiol 2016;92:93–95 280 Brodehl A, Dieding M, Biere N, et al Functional characterization of the novel DES mutation p.L136P associated with dilated cardiomyopathy reveals a dominant filament assembly defect J Mol Cell Cardiol 2016;91:207–214 281 LeWinter MM, Granzier H Cardiac titin: A multifunctional giant Circulation 2010;121:2137–2145 282 Chauveau C, Rowell J, Ferreiro A A rising titan: TTN review and mutation update Hum Mutat 2014;35:1046–1059 283 Labeit S, Gautel M, Lakey A, Trinick J Towards a molecular understanding of titin EMBO J 1992;11:1711–1716 284 Herman DS, Lam L, Taylor MR, et al Truncations of titin causing dilated cardiomyopathy N Engl J Med 2012;366:619– 628 285 Hinson JT, Chopra A, Nafissi N, et al Heart disease Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy Science 2015;349:982–986 286 Barrangou R, Fremaux C, Deveau H, et al CRISPR provides acquired resistance against viruses in prokaryotes Science 2007;315:1709– 1712 287 Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product J Bacteriol 1987;169:5429–5433 288 Jinek M, Chylinski K, Fonfara I, et al A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity Science 2012;337:816–821 289 Carroll KJ, Makarewich CA, McAnally J, et al A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9 Proc Natl Acad Sci USA 2016;113:338–343 290 El Refaey M, Xu L, Gao Y, et al In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice Circ Res 2017 291 Long C, Amoasii L, Mireault AA, et al Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy Science 2016;351:400–403 292 Nelson CE, Hakim CH, Ousterout DG, et al In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy Science 2016;351:403–407 293 Ma H, Marti-Gutierrez N, Park SW, et al Correction of a pathogenic gene mutation in human embryos Nature 2017
Ngày đăng: 22/10/2022, 11:33
Xem thêm: